Healthcare provider profile · identity verified

Vikas Agarwal, M.D.

Internal Medicine · SAINT JOSEPH, MO · NPI 1306939244

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1057	281
Metoprolol Succinate	Metoprolol Succinate	800	233
Amlodipine Besylate	Amlodipine Besylate	706	225
Torsemide	Torsemide	488	163
Spironolactone	Spironolactone	463	156
Losartan Potassium	Losartan Potassium	401	110
Levothyroxine Sodium	Levothyroxine Sodium	385	109
Rosuvastatin Calcium	Rosuvastatin Calcium	371	109
Lisinopril	Lisinopril	365	117
Metformin Hcl	Metformin Hcl	324	88
Omeprazole	Omeprazole	293	93
Prednisone	Prednisone	261	146
Carvedilol	Carvedilol	215	60
Duloxetine Hcl	Duloxetine Hcl	207	61
Pantoprazole Sodium	Pantoprazole Sodium	196	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	144	47
Furosemide	Furosemide	136	37
Glimepiride	Glimepiride	125	37
Sertraline Hcl	Sertraline Hcl	125	45
Escitalopram Oxalate	Escitalopram Oxalate	124	36
Simvastatin	Simvastatin	120	33
Lorazepam	Lorazepam	95	23
Bupropion Xl	Bupropion Hcl	94	23
Eliquis	Apixaban	92	23
Clopidogrel	Clopidogrel Bisulfate	89	30
Metoprolol Tartrate	Metoprolol Tartrate	88	26
Alprazolam	Alprazolam	84	31
Quetiapine Fumarate	Quetiapine Fumarate	82	34
Citalopram Hbr	Citalopram Hydrobromide	79	22
Ozempic	Semaglutide	78	13
Propranolol Hcl	Propranolol Hcl	78	25
Valsartan	Valsartan	77	23
Doxycycline Hyclate	Doxycycline Hyclate	76	64
Tamsulosin Hcl	Tamsulosin Hcl	76	26
Donepezil Hcl	Donepezil Hcl	75	28
Allopurinol	Allopurinol	67	19
Tramadol Hcl	Tramadol Hcl	66	29
Gabapentin	Gabapentin	65	26
Albuterol Sulfate Hfa	Albuterol Sulfate	64	37
Memantine Hcl	Memantine Hcl	63	13
Trazodone Hcl	Trazodone Hcl	63	12
Jardiance	Empagliflozin	62	22
Trulicity	Dulaglutide	60	suppressed
Buspirone Hcl	Buspirone Hcl	55	11
Nortriptyline Hcl	Nortriptyline Hcl	55	14
Diazepam	Diazepam	53	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	52	42
Famotidine	Famotidine	50	13
Venlafaxine Hcl Er	Venlafaxine Hcl	46	13
Warfarin Sodium	Warfarin Sodium	46	13
Azithromycin	Azithromycin	44	37
Finasteride	Finasteride	43	11
Pravastatin Sodium	Pravastatin Sodium	42	13
Pioglitazone Hcl	Pioglitazone Hcl	41	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	suppressed
Chlorthalidone	Chlorthalidone	38	12
Zolpidem Tartrate	Zolpidem Tartrate	38	11
Telmisartan	Telmisartan	36	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	34
Metformin Hcl Er	Metformin Hcl	35	13
Montelukast Sodium	Montelukast Sodium	33	12
Terazosin Hcl	Terazosin Hcl	33	12
Topiramate	Topiramate	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	14
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Clonazepam	Clonazepam	28	15
Nifedipine Er	Nifedipine	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	25	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Celecoxib	Celecoxib	23	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	18
Arexvy	Rsvpref3 Antigen/As01e/Pf	22	22
Entresto	Sacubitril/Valsartan	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Repatha Sureclick	Evolocumab	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Nitroglycerin	Nitroglycerin	19	18
Colchicine	Colchicine	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Sotalol	Sotalol Hcl	18	suppressed
Meloxicam	Meloxicam	17	suppressed
Primidone	Primidone	17	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	16
Tradjenta	Linagliptin	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Benazepril Hcl	Benazepril Hcl	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Danazol	Danazol	13	suppressed
Fluconazole	Fluconazole	13	12
Fluocinonide	Fluocinonide	13	12
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Estradiol	Estradiol	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Atenolol	Atenolol	11	suppressed
Dexmethylphenidate Hcl	Dexmethylphenidate Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error